2026. Therapeutic Use of Tolvaptan in Cancer-Related Hyponatremia: Benefits, Risks, and Clinical Guidance. International Journal of Emerging Research in Applied Medical Sciences. 2, 4 (Apr. 2026), 10–18. DOI:https://doi.org/10.65477/j29hcv64.